Table 4.
Univariate predictors of inpatient PPI use
| PPI prescribed | PPI not prescribed | P value | |
|---|---|---|---|
| N | 458 | 484 | |
| Age | 66.0 yrs | 60.8 yrs | <0.0001 |
| Length of stay | 6.8 days | 5.8 days | 0.006 |
| Gender | |||
| Male | 253 (46%) | 294 (54%) | 0.09 |
| Female | 205 (52%) | 190 (48%) | |
| History of GERD | 109/458 (24%) | 27/484 (6%) | <0.0001 |
| History of PUD/UGIB | 51/458 (11%) | 15/484 (3%) | 0.0003 |
| Outpatient meds | |||
| PPI | 326/458 (71%) | 15/484 (3%) | <0.0001 |
| Aspirin | 183/458 (40%) | 151/484 (31%) | 0.005 |
| Clopidogrel | 37/458 (8%) | 21/484 (4%) | 0.02 |
| NSAID | 24/458 (5%) | 23/484 (5%) | 0.73 |
| Glucocorticoid | 45/458 (10%) | 14/484 (3%) | <0.0001 |